PULSE BIOSCIENCES, INC. Stockholders Equity

Quick Answer

PULSE BIOSCIENCES, INC. reported Stockholders Equity of $80.66 million for fiscal year 2025.

PULSE BIOSCIENCES, INC. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $80.66M -29.8%
2024 $114.86M +158.9%
2023 $44.36M +2073.3%
2022 -$2.25M -106.3%
2021 $35.69M +55.9%
2020 $22.89M -25.5%
2019 $30.74M -53.7%
2018 $66.33M +44.2%
2017 $45.99M +81.8%
2016 $25.30M +85.1%
2015 $13.66M -15.0%
2014 $16.07M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $92.69M +17.1% -11.3%
June 30, 2025 $104.49M +287.4% -11.8%
March 31, 2025 $118.45M +226.4% +3.1%
December 31, 2024 $114.86M +158.9% +45.2%
September 30, 2024 $79.13M +51.8% +193.4%
June 30, 2024 $26.97M -55.4% -25.7%
March 31, 2024 $36.29M +440.2% -18.2%
December 31, 2023 $44.36M +2073.3% -14.9%
  • PULSE BIOSCIENCES, INC. showed a decrease of -29.8% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2014–2025 period, PULSE BIOSCIENCES, INC.’s stockholders equity has grown by 401.8% (from $16.07 million to $80.66 million).
  • The most recent figure is from PULSE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment